Evidence map›Paper›PMID 37652021›Full record

ArticleImmunity2023

Mural cell-derived chemokines provide a protective niche to safeguard vascular macrophages and limit chronic inflammation.

Kami Pekayvaz, Christoph Gold, Parandis Hoseinpour, Anouk Engel, Alejandro Martinez-Navarro, Luke Eivers, Raffaele Coletti, Markus Joppich, Flávio Dionísio, Rainer Kaiser and 21 more

Open access · hybridAbstract read
In one paragraph

Article in Immunity, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Mutant KRAS in brain endothelial cells promotes vascular inflammation and impairs vascular integrity in brain arteriovenous malformation.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  5. Liver Kinase B1 in CD11cAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 6 institutions in 3 countries.

Kami PekayvazMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany. Electronic address: kami.pekayvaz@med.uni-muenchen.de.
Christoph GoldMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
Parandis HoseinpourMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
Anouk EngelMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany.
Alejandro Martinez-NavarroMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany.
Luke EiversMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany.
Raffaele ColettiMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany.
Markus JoppichDepartment of Informatics, Ludwig-Maximilians-Universität München, Munich, Germany.
Flávio DionísioMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
Rainer KaiserMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
Lukas TomasMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
Aleksandar JanjicAnthropology and Human Genomics, Faculty of Biology, Ludwig-Maximilians University, Munich, Germany.
Maximilian KnottInstitute of Pathology, Ludwig-Maximilian University Munich, Munich, Germany.
Fitsumbirhan MehariMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany.
Vivien PolewkaMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany.
Megan KirschnerMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany.
Annegret BodaMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany.
Leo NicolaiMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
Heiko SchulzInstitute of Pathology, Ludwig-Maximilian University Munich, Munich, Germany.
Anna TitovaMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany.
Badr KilaniMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany.
Michael LorenzMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany.
Günter Fingerle-RowsonDepartment I of Internal Medicine, University Hospital Cologne, Cologne, Germany.
Richard BucalaDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
Wolfgang EnardAnthropology and Human Genomics, Faculty of Biology, Ludwig-Maximilians University, Munich, Germany.
Ralf ZimmerDepartment of Informatics, Ludwig-Maximilians-Universität München, Munich, Germany.
Christian WeberDZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany; Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximillian-Universität (LMU) München, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.
Peter LibbyDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Christian SchulzMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
Steffen MassbergMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
Konstantin StarkMedizinische Klinik und Poliklinik I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany. Electronic address: konstantin.stark@med.uni-muenchen.de.
LMU Klinikum · DELudwig-Maximilians-Universität München · DEBrigham and Women's Hospital · USMaastricht University · NLUniversity Hospital Cologne · DEYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Mechanisms and Modulation of Accelerated Atherosclerosis in Clonal HematopoiesisR01HL163099 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LIBBY, PETER · 2022 to 2025
$2.6M
Novel mechanisms of the thrombotic complications of atherosclerosisR01HL134892 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LIBBY, PETER · 2019 to 2022
$1.7M
European Research Council 947611NCATS NIH HHS UL1 TR001863NHLBI NIH HHS R01 HL134892NHLBI NIH HHS R01 HL163099
6 · The paper itself

Abstract

Maladaptive, non-resolving inflammation contributes to chronic inflammatory diseases such as atherosclerosis. Because macrophages remove necrotic cells, defective macrophage programs can promote chronic inflammation with persistent tissue injury. Here, we investigated the mechanisms sustaining vascular macrophages. Intravital imaging revealed a spatiotemporal macrophage niche across vascular beds alongside mural cells (MCs)-pericytes and smooth muscle cells. Single-cell transcriptomics, co-culture, and genetic deletion experiments revealed MC-derived expression of the chemokines CCL2 and MIF, which actively preserved macrophage survival and their homeostatic functions. In atherosclerosis, this positioned macrophages in viable plaque areas, away from the necrotic core, and maintained a homeostatic macrophage phenotype. Disruption of this MC-macrophage unit via MC-specific deletion of these chemokines triggered detrimental macrophage relocalizing, exacerbated plaque necrosis, inflammation, and atheroprogression. In line, CCL2 inhibition at advanced stages of atherosclerosis showed detrimental effects. This work presents a MC-driven safeguard toward maintaining the homeostatic vascular macrophage niche.

Indexed as

AtherosclerosisPlaque, AtheroscleroticChemokinesHumansInflammationMacrophagesNecrosisChemokinesatherosclerosisCCL2chemokineschronic inflammationmacrophagesMIFmural cellspericytessmooth muscle cellsvascular macrophages

Identifiers

PMID37652021
PMCPMC10588993
OpenAlexW4386295594

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.